Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 2/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31456080 | 0.87 | HTR2A (0.52) | TAAR1HTR2AHTR2CHTR2B | |
| SCHEMBL31498057 | 0.86 | TAAR1 (0.71) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL11739911 | 0.86 | TAAR1 (0.71) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL27878290 | 0.84 | TAAR1 (0.54) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL29279603 | 0.84 | TAAR1 (0.47) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL30855258 | 0.84 | TAAR1 (0.51) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL31456000 | 0.83 | TAAR1 (0.50) | TAAR1HTR2A | |
| SCHEMBL29279530 | 0.83 | TAAR1 (0.46) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL24765641 | 0.83 | TAAR1 (0.53) | TAAR1HTR2AHTR1AHTR2CHTR2B | |
| SCHEMBL11614044 | 0.83 | TAAR1 (0.53) | TAAR1HTR2AHTR1AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059373-A1 | NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |